Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2006;1(3):137–152. [Article in German] doi: 10.1007/s11812-006-0017-2

Akute infektiöse Diarrhoe

Gertrude Seiberl 1,✉, Elisabeth Bischof 1, Christoph Wenisch 1
PMCID: PMC7104570  PMID: 17674509

The content is available as a PDF (177.7 KB).

Literatur

  1. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoea ldisease; A ten year update. Bull World Health Organ. 1992;70:705–714. [PMC free article] [PubMed] [Google Scholar]
  2. Herikstad H, Yang S, Van Gilder TJ, Vugia D, Hadler J, Blake P, Deneen V, Shiferaw B, Angulo FJ. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996–7. Epidemiol Infect. 2002;129:9–17. doi: 10.1017/S0950268801006628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med. 2004;350:38–47. doi: 10.1056/NEJMcp031534. [DOI] [PubMed] [Google Scholar]
  4. Guerrant RL, Araujo V, Soares E. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol. 1992;30:1238–1242. doi: 10.1128/jcm.30.5.1238-1242.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK, Infectious Diseases Society of America Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331–351. doi: 10.1086/318514. [DOI] [PubMed] [Google Scholar]
  6. Lopmann B, Reacher MH, van Duijnhoven Y, Hanon FX, Brown B, Koopmans M. Viral Gastroenteritis Outbreaks in Europe, 1995–2000. Emerg Infect Dis. 2003;9:90–96. doi: 10.3201/eid0901.020184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaplan JE, Feldmann R, Campbell DS, Lookabaugh C, Gary GW. The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health. 1982;72:1329–1332. doi: 10.2105/AJPH.72.12.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Zahorsky J. Hyperemesis heimis or the winter vomiting disease. Arch Pediatr. 1929;46:391. [Google Scholar]
  9. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torven M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szucs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M. Increase in viral gastoenteritis outbreaks in Europe and epidemic spread of new Norovirus variant. Lancet. 2004;363:682–688. doi: 10.1016/S0140-6736(04)15641-9. [DOI] [PubMed] [Google Scholar]
  10. Anderson EJ, Weber SG. Rotavirus infections in adults. Lancet Infect Dis. 2004;4:91–99. doi: 10.1016/S1473-3099(04)00928-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ball JM, Tian P, Zeng CQ, Morris AP, Estes MK. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science. 1996;272:101–104. doi: 10.1126/science.272.5258.101. [DOI] [PubMed] [Google Scholar]
  12. Widdowson MA, Bresee JS, Gentsch JR, Glass RI. Rotavirus disease and its prevention. Curr Opin Gastroenterol. 2005;21:26–31. [PubMed] [Google Scholar]
  13. Neal KR, Briji SO, Slack RC, Hawkey CJ, Logan RF. Recent treatment with H2 antagonists and gastric surgery as risk factors for Salmonella infection. BMJ. 1994;308:176. doi: 10.1136/bmj.308.6922.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Parry CM, Hien TT, Dougan G, White NJ, Farrarv JJ. Medical progress: Typhoid fever. N Engl J Med. 2002;347:1770–1782. doi: 10.1056/NEJMra020201. [DOI] [PubMed] [Google Scholar]
  15. Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni Infection in humans. J Infect Dis. 1988;157:472–479. doi: 10.1093/infdis/157.3.472. [DOI] [PubMed] [Google Scholar]
  16. Bennish ML. Potentially lethal complications shigellosis. Rev Infect Dis. 1991;13(Suppl 4):S319. doi: 10.1093/clinids/13.supplement_4.s319. [DOI] [PubMed] [Google Scholar]
  17. Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI. Prothrombotic coagulation abnormalities preceeding the haemolytic-uremic syndrome. N Engl J Med. 2002;346:23–32. doi: 10.1056/NEJMoa011033. [DOI] [PubMed] [Google Scholar]
  18. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342:1930–1936. doi: 10.1056/NEJM200006293422601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Saha D, Karim MM, Khan WA, Ahmed S, Salam MA, Bennish ML. Single-dose Azithromycin fo the treatment of cholera in adults. N Engl J Med. 2006;354:2452–2462. doi: 10.1056/NEJMoa054493. [DOI] [PubMed] [Google Scholar]
  20. Khan WA, Bennish ML, Seas C, Khan EH, Ronan A, Dhar U, Busch W, Salam MA. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139. Lancet. 1996;348:296–300. doi: 10.1016/S0140-6736(96)01180-4. [DOI] [PubMed] [Google Scholar]
  21. Herwaldt BL. Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin Infect Dis. 2000;31:1040–1057. doi: 10.1086/314051. [DOI] [PubMed] [Google Scholar]
  22. Hoge CW, Shlim DR, Ghimire M, Rabold JG, Pandey P, Walch A, Rajah R, Gaudio P, Echeverria P. Placebo-contolled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal. Lancet. 1995;345:691–693. doi: 10.1016/S0140-6736(95)90868-4. [DOI] [PubMed] [Google Scholar]
  23. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomised, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 2001;184:103–106. doi: 10.1086/321008. [DOI] [PubMed] [Google Scholar]
  24. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334–339. doi: 10.1056/NEJMcp011603. [DOI] [PubMed] [Google Scholar]
  25. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and srum levels of IgG antibody against toxin A. N Engl J Med. 2000;342:390–397. doi: 10.1056/NEJM200002103420604. [DOI] [PubMed] [Google Scholar]
  26. Jiang ZD, DuPont HL, Garey K, Price M, Graham G, Okhuysen P, Dao-Tran T, LaRocco M. A common polymorphism in the Interleukin 8 Gene Promotor is associated with Clostridium difficile diarrhea. Am J Gastroenterol. 2006;101:1112–1116. doi: 10.1111/j.1572-0241.2006.00482.x. [DOI] [PubMed] [Google Scholar]
  27. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomcin, teicoplanin, metronidazole and fusidic acid fort he treatment of Clodridium difficile-associated diarrhea. Clin Infect Dis. 1996;23:423. doi: 10.1093/clinids/22.5.813. [DOI] [PubMed] [Google Scholar]

Articles from Wiener Klinische Wochenschrift. Education are provided here courtesy of Nature Publishing Group

RESOURCES